Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates

被引：174
|
作者：
Dalrymple, Annette
Wild, Edward J.
Joubert, Richard
Sathasivam, Kirupa
Bjorkqvist, Maria
Petersen, Asa
Jackson, Graham S.
Isaacs, Jeremy D.
Kristiansen, Mark
Bates, Gillian P.
Leavitt, Blair R.
Keir, Geoff
Ward, Malcolm
Tabrizi, Sarah J.
机构：
[1] Natl Hosp Neurol & Neurosurg, Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England
[2] Proteome Sci PLC, Surrey, England
[3] Inst Neurol, Dept Neurodegenerat, London WC1N 3BG, England
[4] Kings Coll London, Guys Hosp, Sch Med, London WC2R 2LS, England
[5] Wallenberg Neurosci Ctr, Dept Expt Med Sci, Neuronal Survival Unit, Lund, Sweden
[6] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 1M9, Canada
[7] Natl Hosp Neurol & Neurosurg, Neuroimmunol Lab, London WC1N 3BG, England
来源：
JOURNAL OF PROTEOME RESEARCH | 2007年 / 6卷 / 07期
基金：
英国医学研究理事会; 英国惠康基金;
关键词：
Huntington's disease; plasma; neuroinflammation; proteomics; 2D electrophoresis; LC/MS/MS; MALDI-TOF; ELISA; biomarkers;
D O I：
10.1021/pr0700753
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Huntington's disease (HD) causes widespread CNS changes and systemic abnormalities including endocrine and immune dysfunction. HD biomarkers are needed to power clinical trials of potential treatments. We used multiplatform proteomic profiling to reveal plasma changes with HD progression. Proteins of interest were evaluated using immunoblotting and ELISA in plasma from 2 populations, CSF and R6/2 mice. The identified proteins demonstrate neuroinflammation in HD and warrant further investigation as possible biomarkers.
引用
收藏
页码：2833 / 2840
页数：8
相关论文
共 50 条
  • [21] Tau: a biomarker of Huntington's disease
    Lepinay, Eva
    Cicchetti, Francesca
    MOLECULAR PSYCHIATRY, 2023, 28 (10) : 4070 - 4083
  • [22] Tau: a biomarker of Huntington’s disease
    Eva Lepinay
    Francesca Cicchetti
    Molecular Psychiatry, 2023, 28 : 4070 - 4083
  • [23] Proteomic profiling of cerebrospinal fluid reveals TKT as a potential biomarker for medulloblastoma
    Kim, Joo Whan
    Choi, Seung Ah
    Dan, Kisoon
    Koh, Eun Jung
    Ha, Saehim
    Phi, Ji Hoon
    Kim, Kyung Hyun
    Han, Dohyun
    Kim, Seung-Ki
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Determination of biomarker candidates for the placenta accreta spectrum by plasma proteomic analysis
    Rauf Melekoglu
    Seyma Yasar
    Cemil Colak
    Murat Kasap
    Umran Karabulut Dogan
    Saim Yologlu
    Ercan Yilmaz
    Sherif Shazly
    Scientific Reports, 14
  • [25] Determination of biomarker candidates for the placenta accreta spectrum by plasma proteomic analysis
    Melekoglu, Rauf
    Yasar, Seyma
    Colak, Cemil
    Kasap, Murat
    Dogan, Umran Karabulut
    Yologlu, Saim
    Yilmaz, Ercan
    Shazly, Sherif
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [26] Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease
    Kong, Geraldine
    Kim-Anh Le Cao
    Judd, Louise M.
    Li, ShanShan
    Renoir, Thibault
    Hannan, Anthony J.
    NEUROBIOLOGY OF DISEASE, 2020, 135
  • [27] Salivary Huntington Protein as a Peripheral Biomarker for Huntington's Disease
    Corey-Bloom, Jody
    Aikin, Alaina
    Garza, Madeline
    Haque, Ameera
    Park, Sungmee
    Herndon, Andrew
    Thomas, Elizabeth
    NEUROLOGY, 2016, 86
  • [28] Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosis
    Garay-Baquero, Diana J.
    White, Cory H.
    Walker, Naomi F.
    Tebruegge, Marc
    Schiff, Hannah F.
    Ugarte-Gil, Cesar
    Morris-Jones, Stephen
    Marshall, Ben G.
    Manousopoulou, Antigoni
    Adamson, John
    Vallejo, Andres F.
    Bielecka, Magdalena K.
    Wilkinson, Robert J.
    Tezera, Liku B.
    Woelk, Christopher H.
    Garbis, Spiros D.
    Elkington, Paul
    JCI INSIGHT, 2020, 5 (18)
  • [29] Searching for biomarkers in Huntington's disease using a proteomic analysis of cerebrospinal fluid and plasma
    Leavitt, BR
    Lindner, RA
    Decolongon, J
    Remediakis, C
    Prasad, S
    Sebastian, L
    Olsson, R
    McKay, M
    Wetterhall, M
    Hunt, S
    Goodall, T
    Wilson, N
    Harry, J
    MOVEMENT DISORDERS, 2005, 20 (09) : 1239 - 1239
  • [30] Plasma proteomic profiling in postural orthostatic tachycardia syndrome (POTS) reveals new disease pathways
    Johansson, Madeleine
    Yan, Hong
    Welinder, Charlotte
    Vegvari, Akos
    Hamrefors, Viktor
    Back, Magnus
    Sutton, Richard
    Fedorowski, Artur
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345